Cargando…

The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review

The inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive, inflammatory conditions of the gastrointestinal tract. Imbalance in the gut microbial community, or dysbiosis, and the subsequent immune response, represent the critical rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Axelrad, Jordan E., Cadwell, Ken H., Colombel, Jean-Frederic, Shah, Shailja C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020742/ https://www.ncbi.nlm.nih.gov/pubmed/33868457 http://dx.doi.org/10.1177/17562848211004493

Ejemplares similares

Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection
por: Axelrad, Jordan E., et al.
Publicado: (2022)

Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses
por: Agrawal, Manasi, et al.
Publicado: (2021)

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
por: Axelrad, Jordan E., et al.
Publicado: (2020)

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
por: Mahmoud, Remi, et al.
Publicado: (2019)

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
por: Mahmoud, Remi, et al.
Publicado: (2018)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases
por: Axelrad, Jordan E., et al.
Publicado: (2019)

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies
por: Agrawal, Manasi, et al.
Publicado: (2019)

There was collusion: Microbes in inflammatory bowel disease
por: Wong, Serre-Yu, et al.
Publicado: (2018)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
por: Colombel, Jean-Frédéric, et al.
Publicado: (2020)

Conjugal inflammatory bowel disease: a systematic review and European survey
por: Costa-Santos, Maria Pia, et al.
Publicado: (2021)

Sex-based differences in inflammatory bowel diseases: a review
por: Rustgi, Sheila D., et al.
Publicado: (2020)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Gastrointestinal Dopamine in Inflammatory Bowel Diseases: A Systematic Review
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2021)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data
por: Axelrad, Jordan E, et al.
Publicado: (2020)

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—a Systematic Review and Meta-analysis
por: Shah, Shailja C., et al.
Publicado: (2019)

Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient
por: Dunleavy, Katie A, et al.
Publicado: (2021)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021)

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022)

Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease
por: Ruel, Joannie, et al.
Publicado: (2016)

Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
por: Maronek, Martin, et al.
Publicado: (2020)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

Gastrointestinal hypoalgesia in inflammatory bowel disease
por: Coates, Matthew D., et al.
Publicado: (2020)

Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA
por: Ungaro, Ryan C, et al.
Publicado: (2022)

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
por: Torres, Joana, et al.
Publicado: (2016)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Obliterative Muscularization of the Small Bowel Submucosa in Fibrostenotic Crohn's Disease
por: McNeill, Matthew B., et al.
Publicado: (2020)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022)

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
por: Alayo, Quazim A, et al.
Publicado: (2022)

Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons
por: Tontini, Gian Eugenio, et al.
Publicado: (2021)

Systematic review: the role of psychological stress in inflammatory bowel disease
por: Black, Jacqueline, et al.
Publicado: (2022)

Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study
por: Mårild, Karl, et al.
Publicado: (2022)

Long‐term safety of vedolizumab for inflammatory bowel disease
por: Loftus, Edward V., et al.
Publicado: (2020)

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
por: Shah, Shailja C., et al.
Publicado: (2019)

Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
por: Axelrad, Jordan E., et al.
Publicado: (2018)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2011)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t75uke46mu9c2n69nip0lcdlgq